Form 8.3 - Allergan Plc
March 05 2020 - 10:35AM
Dow Jones News
TIDM0Y7T TIDM0QCV
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING
1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) State Street Global Advisors &
Affiliates
--------------------------------------------- -------------------------------
Company dealt in Allergan plc
--------------------------------------------- -------------------------------
Class of relevant security to which US$0.0001 ordinary shares
the dealings being disclosed relate (Note 2)
--------------------------------------------- -------------------------------
Date of dealing 04(th) March 2020
--------------------------------------------- -------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
Long Short
------------------------------------- -------------------- -----------
Number (%) Number (%)
------------------------------------- ---------- -------- ------ ---
(1) Relevant securities 13,454,456 4.08794%
------------------------------------- ---------- -------- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------- ---------- -------- ------ ---
(3) Options and agreements to
purchase/sell N/A
------------------------------------- ---------- -------- ------ ---
Total 13,454,456 4.08794%
------------------------------------- ---------- -------- ------ ---
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
Class of relevant security: Long Short
------------------------------------------- ----------- -----------
Number (%) Number (%)
------------------------------------------- ------ --- ------ ---
(1) Relevant securities N/A
------------------------------------------- ------ --- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------------- ------ --- ------ ---
(3) Options and agreements to purchase/sell N/A
------------------------------------------- ------ --- ------ ---
Total N/A
------------------------------------------- ------ --- ------ ---
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note 5)
-------------- ----------------------------- -----------------------
Purchase 300 195.33
-------------- ----------------------------- -----------------------
Purchase 700 195.94
-------------- ----------------------------- -----------------------
Purchase 500 195.94
-------------- ----------------------------- -----------------------
Purchase 4,500 195.94
-------------- ----------------------------- -----------------------
Purchase 100 194.82
-------------- ----------------------------- -----------------------
Purchase 2,200 195.94
-------------- ----------------------------- -----------------------
Purchase 400 195.94
-------------- ----------------------------- -----------------------
Purchase 1,600 195.94
-------------- ----------------------------- -----------------------
Purchase 2,758 195.94
-------------- ----------------------------- -----------------------
Purchase 11,492 195.94
-------------- ----------------------------- -----------------------
Purchase 138 195.94
-------------- ----------------------------- -----------------------
Purchase 1,024 195.94
-------------- ----------------------------- -----------------------
Purchase 138 195.94
-------------- ----------------------------- -----------------------
Purchase 600 195.94
-------------- ----------------------------- -----------------------
Purchase 176 195.94
-------------- ----------------------------- -----------------------
Purchase 176 195.94
-------------- ----------------------------- -----------------------
Purchase 375 195.94
-------------- ----------------------------- -----------------------
Purchase 540 195.94
-------------- ----------------------------- -----------------------
Purchase 46 194.08
-------------- ----------------------------- -----------------------
Sale 400 195.94
-------------- ----------------------------- -----------------------
Sale 500 195.94
-------------- ----------------------------- -----------------------
Sale 2,200 195.94
-------------- ----------------------------- -----------------------
Sale 4,500 195.94
-------------- ----------------------------- -----------------------
Sale 1,600 195.94
-------------- ----------------------------- -----------------------
Sale 964 195.94
-------------- ----------------------------- -----------------------
Sale 400 195.94
-------------- ----------------------------- -----------------------
Sale 700 195.94
-------------- ----------------------------- -----------------------
Sale 44 195.94
-------------- ----------------------------- -----------------------
Sale 378 195.94
-------------- ----------------------------- -----------------------
Sale 227 195.94
-------------- ----------------------------- -----------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
------------- --------------------- ----------------------------- --------------
N/A
------------- --------------------- ----------------------------- --------------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money
e.g. call option purchasing securities to which price American, date paid/received
varying etc. the option relates European etc. per unit (Note 5)
(Note 7)
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
N/A
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
(ii) Exercising
Product name, Number of securities Exercise price per
e.g. call option unit (Note 5)
----------------- -------------------- ------------------
N/A
----------------- -------------------- ------------------
(d) Other dealings (including transactions in respect of new securities)
(Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
--------------------- ------- -------------------------
N/A
--------------------- ------- -------------------------
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or
derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person
relating to the voting rights of any relevant securities
under any option referred to on this form or relating
to the voting rights or future acquisition or disposal
of any relevant securities to which any derivative
referred to on this form is referenced. If none, this
should be stated.
-----------------------------------------------------------
N/A
-----------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) NO
------------------------------------------------------- -----------------
Date of disclosure 05(th) March 2020
------------------------------------------------------- -----------------
Contact name Lionel Colaco
------------------------------------------------------- -----------------
Telephone number 020 33956098
------------------------------------------------------- -----------------
If a connected EFM, name of offeree/offeror with which N/A
connected
------------------------------------------------------- -----------------
If a connected EFM, state nature of connection (Note N/A
10)
------------------------------------------------------- -----------------
(END) Dow Jones Newswires
March 05, 2020 10:20 ET (15:20 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Mar 2024 to Apr 2024
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Apr 2023 to Apr 2024
